MiNK Therapeutics, Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2021 | $-4.2M | $-4.2M | $39.5K | $283.0K |
| Jun 2021 | $-3.4M | $-3.5M | $97.9K | — |
| Sep 2021 | $-3.5M | $-3.6M | $111.8K | — |
| Mar 2022 | $-4.2M | $-4.2M | — | $785.5K |
| Jun 2022 | $-4.6M | $-4.6M | — | — |
| Sep 2022 | $-5.6M | $-5.6M | — | — |
| Mar 2023 | $-4.4M | $-4.4M | $13.5K | $921.1K |
| Jun 2023 | $-4.2M | $-4.2M | $37.0K | — |
| Sep 2023 | $-4.2M | $-4.2M | $23.0K | — |
| Mar 2024 | $-2.5M | $-2.5M | — | $592.0K |
| Jun 2024 | $-2.3M | $-2.3M | — | — |
| Sep 2024 | $-3.0M | $-3.0M | — | — |
| Mar 2025 | $-1.3M | $-1.3M | — | $591.1K |
| Jun 2025 | $-1.6M | $-1.6M | — | — |
| Sep 2025 | $-941.3K | $-941.3K | — | — |